Delivery Order SPE2DB22D1106-SPE2DB24FFGQ4
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565418587 - Moxifloxacin HCL 400 mg Tablets in bottles of 30. The award, valued at $1,891.35, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside designation...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,565,259 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract has a firm fixed-price delivery order type with a ceiling value of $2,191.81 and a completion date of July 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,455.00 firm fixed price delivery order is for the provision of 4,564,759,307 units of the pharmaceutical Moxifloxacin HCL 400 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to deliver a comprehensive range of pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Moxifloxacin HCL 400 mg tablets. The $5,425.11 firm fixed-price contract has a completion date of September 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,345.50 firm fixed-price delivery order is for the supply of 4,564,783,446 units of the antibiotic medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,561.19 firm fixed-price delivery order is for the supply of Moxifloxacin HCL 400 mg tablets, a medication used to treat bacterial infections. The contract has an ultimate completion date of June 25, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,760.00 firm fixed-price delivery order is for the supply of 50 units of 400 mg moxifloxacin HCl tablets, with a completion date of June 26, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,867.20 Firm Fixed Price Delivery Order contract is for the supply of 4,563,604,495 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablets, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,567,049,952 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,342.70 and is a firm fixed price delivery order without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery...
This federal contract award is for the delivery of 4,565,712,216 units of the pharmaceutical product Moxifloxacin HCl 400 mg Tablet UD 50s. The contract, valued at $7,576.84, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of September 9, 2024. This award is not associated with a set-aside...